Showing results (51-60 of 83) with videos related to
Sort By:
Pageof 9
British Journal of Cancer|November 1, 1996
Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanomaM Altomonte, R Montagner, E Fonsatti, et al.The Journal of Clinical Investigation|September 1, 1997
Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement-mediated cytotoxicityL I Brasoveanu, E Fonsatti, A Visintin, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1996
Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cellsL I Brasoveanu, M Altomonte, E Fonsatti, et al.International Journal of Cancer|May 15, 1985
HLA and prognostic factors in primary breast cancerR V Iaffaioli, M Maio, G Ruggiero, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2013
Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trialsJ D Wolchok, J S Weber, M Maio, et al.Journal of Cellular Physiology|October 31, 2000
Overexpression of protectin (CD59) down-modulates the susceptibility of human melanoma cells to homologous complementS Coral, E Fonsatti, L Sigalotti, et al.Oncoimmunology|September 26, 2015
Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse modelsA Covre, S Coral, H Nicolay, et al.Journal of Clinical Microbiology|February 1, 1985
Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristicsT E Kiehn, F F Edwards, P Brannon, et al.European Journal of Cancer (Oxford, England : 1990)|April 7, 2012
Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study)K Johnston, A R Levy, P Lorigan, et al.British Journal of Cancer|August 23, 2012
Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implicationsS Coral, A Covre, H J M G Nicolay, et al.Pageof 9